Oxford BioDynamics Plc

AIM:OBD Stock Report

Market Cap: UK£3.7m

Oxford BioDynamics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

AIM:OBD Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
28 Nov 24BuyUK£645David Mark HolbrookIndividual51,640UK£0.012
28 Nov 24BuyUK£2,730Thomas GuielIndividual218,370UK£0.012
28 Nov 24BuyUK£2,525Alexandre AkoulitchevIndividual202,034UK£0.012
28 Nov 24BuyUK£6,558Jon Anthony BurrowsIndividual524,604UK£0.012
28 Nov 24BuyUK£2,142Ewan HunterIndividual171,353UK£0.012
28 Nov 24BuyUK£2,338Paul StockdaleIndividual187,041UK£0.012
28 Nov 24BuyUK£1,276Matthew WakefieldIndividual102,043UK£0.012
28 Oct 24BuyUK£645David Mark HolbrookIndividual49,653UK£0.013
28 Oct 24BuyUK£2,399Thomas GuielIndividual184,545UK£0.013
28 Oct 24BuyUK£2,525Alexandre AkoulitchevIndividual194,263UK£0.013
28 Oct 24BuyUK£6,405Jon Anthony BurrowsIndividual492,682UK£0.013
28 Oct 24BuyUK£2,142Ewan HunterIndividual164,763UK£0.013
28 Oct 24BuyUK£2,338Paul StockdaleIndividual179,847UK£0.013
28 Oct 24BuyUK£1,276Matthew WakefieldIndividual98,118UK£0.013

Insider Trading Volume

Insider Buying: OBD insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of OBD?
Owner TypeNumber of SharesOwnership Percentage
Private Companies00%
Public Companies1,666,6660.526%
Individual Insiders13,823,5654.37%
Hedge Funds29,366,4659.28%
General Public76,336,60124.1%
Institutions195,383,27261.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 56.5%.

Top Shareholders

Top 25 shareholders own 63.91% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.28%
Vulpes Investment Management Private Limited
29,366,465UK£344.2k0%0.72%
8.29%
Arbuthnot Latham & Co. Limited, Asset Management Arm
26,240,012UK£307.5k0%1.46%
7.94%
Unicorn Asset Management Ltd.
25,131,526UK£294.5k0%0.05%
4.92%
Lombard Odier Asset Management (Europe) Ltd.
15,568,816UK£182.5k-1.15%no data
3.15%
Seneca Partners Limited
9,978,822UK£117.0k0%0.01%
2.54%
Investec Wealth & Investment Limited
8,055,566UK£94.4k-4.25%no data
2.42%
Chelverton Asset Management Limited
7,650,000UK£89.7k0%0.01%
2.4%
Charles Stanley & Co. Ltd, Asset Management Arm
7,605,672UK£89.1k1,120%no data
2.32%
Alexandre Akoulitchev
7,332,712UK£85.9k5.71%no data
2.05%
UBS Asset Management AG
6,474,885UK£75.9k10.8%no data
1.93%
Lansdowne Partners Limited
6,111,111UK£71.6k0%no data
1.77%
Killik Asset Management
5,611,313UK£65.8k330%0.01%
1.7%
London Wealth Management Limited
5,391,807UK£63.2k0.47%no data
1.66%
Global Prime Partners Ltd, Asset Management Arm
5,268,866UK£61.8k0%15.93%
1.55%
Patronus Partners Limited
4,914,486UK£57.6k84%0.36%
1.48%
Deutsche Bank, Private Banking and Investment Banking Investments
4,688,000UK£54.9k10,100%no data
1.42%
Peel Hunt LLP., Asset Management Arm
4,499,262UK£52.7k121%0.02%
1.39%
HBOS Investment Fund Managers Limited
4,400,587UK£51.6k-4.06%no data
1.19%
UOB Asset Management Limited
3,775,086UK£44.2k2.3%no data
0.93%
LGT Wealth Management UK LLP
2,941,894UK£34.5k-26.7%no data
0.79%
HSBC Global Asset Management (UK) Limited
2,513,846UK£29.5k2.11%no data
0.75%
Barclays Bank PLC, Wealth and Investment Management Division
2,382,582UK£27.9k20.5%no data
0.68%
Nplus1 Singer Advisory LLP, Asset Management Arm
2,162,871UK£25.3k296%0.35%
0.68%
Rathbones Investment Management Limited
2,140,002UK£25.1k-0.14%no data
0.67%
Jon Anthony Burrows
2,106,174UK£24.7k93.4%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 07:29
End of Day Share Price 2024/12/20 00:00
Earnings2024/03/31
Annual Earnings2023/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Oxford BioDynamics Plc is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tara RaveendranShore Capital Group Ltd
null nullStifel, Equities Research
Christian GlennieStifel, Equities Research